← Back to Search

Behavioral Intervention

Supported Exercise Group for Multiple Myeloma (MOTIVATE Trial)

N/A

Waitlist Available

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be undergoing chemotherapy prior to an autologous stem cell transplant as part of their cancer treatment

Have a diagnosis of Multiple Myeloma

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18 months

Awards & highlights

MOTIVATE Trial Summary

This trial aims to determine if people with Multiple Myeloma can participate in a personalized exercise program while receiving chemotherapy before a stem cell transplant. Researchers want to find out if this program, which can be

Who is the study for?

This trial is for individuals with Multiple Myeloma who are about to undergo chemotherapy and a stem cell transplant. Participants should be interested in following a tailored exercise program, which can be done both in-person and virtually.Check my eligibility

What is being tested?

The study is testing whether a customized exercise regimen before stem cell transplantation can help maintain or improve physical fitness, muscle mass, strength, and quality of life during chemotherapy for Multiple Myeloma patients.See study design

What are the potential side effects?

Since the intervention involves supported exercise rather than medication, side effects may include typical exercise-related issues such as muscle soreness or fatigue but will vary based on individual health conditions.

MOTIVATE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am receiving chemotherapy before a stem cell transplant using my own cells.

Select...

I have been diagnosed with Multiple Myeloma.

Select...

I am 18 years old or older.

MOTIVATE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Study completion rate

Secondary outcome measures

Attendance rate

Body height

Body weight

+12 more

MOTIVATE Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Supported Exercise GroupExperimental Treatment1 Intervention

Participants assigned to the exercise group will take part in a 10-week exercise program delivered in-person and through the HEAL-ME app. The program comprises (1) a minimum of one supervised session (in-person or virtual through a Zoom platform embedded in HEAL-ME), (2) a minimum of one independent exercise workout within the HEAL-ME app, and (3) exercise specific education content as per standard care.

Group II: Standard CareActive Control1 Intervention

Participants in this group will receive exercise counseling as per standard care for 10-weeks. This will include: (1) counseling on remaining active during chemotherapy; (2) handouts on the benefits of exercise during chemotherapy, exercise behavior change strategies, and how to exercise safely. Participants will be encouraged to remain as physical active as possible. As per American College of Sports Medicine 2019 guidelines, participants will be advised to take part in moderate intensity exercise for a total of 90 minutes per week.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

886 Previous Clinical Trials

384,748 Total Patients Enrolled

2 Trials studying Multiple Myeloma

106 Patients Enrolled for Multiple Myeloma

Chris Sellar, PhDStudy DirectorUniversity of Alberta

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are potential participants currently able to apply for this ongoing medical study?

"The clinical trial, as stated on clinicaltrials.gov, is presently not seeking participants. Initially shared on April 15th, 2024 and most recently revised on February 19th of the same year. It's worth mentioning that while this study isn't open for recruitment currently, there are a total of 932 other trials welcoming prospective candidates at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Prehab Prior to Stem Cell Transplantation in Multiple Myeloma

2024. "Prehab Prior to Stem Cell Transplantation in Multiple Myeloma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06280924.